Dendritic Molecular Baskets for Selective Binding of Toxic Methotrexate


Kumar N., Finnegan T. J., Taneja S., Rostam D. C., Hansen A. L., Ward C. E., ...Daha Fazla

Angewandte Chemie - International Edition, cilt.64, sa.9, 2025 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 64 Sayı: 9
  • Basım Tarihi: 2025
  • Doi Numarası: 10.1002/anie.202420574
  • Dergi Adı: Angewandte Chemie - International Edition
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, L'Année philologique, Agricultural & Environmental Science Database, Applied Science & Technology Source, Aquatic Science & Fisheries Abstracts (ASFA), CAB Abstracts, Chemical Abstracts Core, Chimica, Compendex, EMBASE, Veterinary Science Database, Nature Index
  • Anahtar Kelimeler: Anticancer Drugs, Host-Guest Chemistry, Inclusion Complexation, Methotrexate, Sequestration
  • Atatürk Üniversitesi Adresli: Evet

Özet

We describe the preparation, assembly, recognition characteristics, and bioactivity of dendritic basket 612−. This novel cavitand has a deep aromatic pocket with three (S)-glutamic acid dendrons at the rim to amplify water solubility and prevent self-association. 1H NMR spectroscopy, calorimetry (ITC), and mass spectrometry (ESI-MS) measurements validate the formation of an inclusion complex between 612− and anticancer drug methotrexate (MTX2−) in water (Kd=9.2 μM). To identify the docking pose, a comparison of computed (DFT and MM) and experimental 1H NMR chemical shifts suggests that MTX2− folds inside 612− (π⋅⋅⋅π), forming HBs with the peptidic dendrons while anchoring (C−H⋅⋅⋅π) to the aromatic pocket through its N-methyl group. In consequence, 612− selectively binds MTX2− in competition with structurally similar folic acid and leucovorin (reversal poisoning agent). While the host is biocompatible (HEK293; IC50>150 μM) and produces inclusion complex [MTX⊂6]14− in cell media, it experiences limitation in pharmacokinetic sequestration of MTX2− as dihydrofolate reductase's affinity to the drug is suggested to prevail over that of 612−. Nonetheless, considering the basket's biocompatibility, tunability, and chemoselectivity, it stands as the leading candidate in the pursuit of an effective abiotic antidote for methotrexate poisoning.